mendelian randomization |
17 |
testosterone |
14 |
chinese |
13 |
secondary prevention |
13 |
vitamin d |
13 |
hypertension |
12 |
ischemic stroke |
12 |
myocardial infarction |
12 |
recurrence |
12 |
exome chip |
10 |
type 2 diabetes |
10 |
berberine |
9 |
mendelian randomization analysis |
8 |
diabetes |
7 |
insulin resistance |
7 |
qt interval |
7 |
cardiovascular disease |
6 |
ischemic heart disease |
6 |
blood pressure |
5 |
cardiovascular risk factors |
5 |
covid-19 |
5 |
estrogen |
5 |
gene |
5 |
menarche |
5 |
menarcheal age |
5 |
meta-analysis |
5 |
puberty |
5 |
randomized controlled trial |
5 |
women |
5 |
blood glucose |
4 |
causal effect |
4 |
efficacy |
4 |
instrumental variable estimate |
4 |
kidney function |
4 |
risk factors |
4 |
safety |
4 |
selection bias |
4 |
sex-specific effect |
4 |
treatment |
4 |
ace inhibitor |
3 |
air pollution |
3 |
anti-androgen |
3 |
aspartate |
3 |
competing risk |
3 |
diabetes mellitus |
3 |
e-cigarettes |
3 |
glucose |
3 |
glycated hemoglobin |
3 |
immune function |
3 |
inflammation |
3 |
instrumental variable analysis |
3 |
placebo-controlled trial |
3 |
pm10 |
3 |
random allocation |
3 |
randomization mr |
3 |
shared etiology |
3 |
smoking |
3 |
unsaturated fatty acid |
3 |
adolescents |
2 |
androgen |
2 |
androgens |
2 |
antihypertensives |
2 |
arachidonic acid |
2 |
asthma |
2 |
atherosclerotic cardiovascular disease |
2 |
big data |
2 |
cardiovascular |
2 |
cerebrovascular accident |
2 |
chronic disease |
2 |
chronic diseases |
2 |
chronic kidney disease |
2 |
clinical trial (topic) |
2 |
coagulation |
2 |
dietary intake |
2 |
early-life exposure |
2 |
fads1 gene |
2 |
fads2 gene |
2 |
folate |
2 |
gender difference |
2 |
genetic analysis |
2 |
healthspan |
2 |
heart diseases |
2 |
heart rate |
2 |
human |
2 |
lifespan |
2 |
linoleic acid |
2 |
lipids |
2 |
men |
2 |
mendelian randomisation |
2 |
obesity |
2 |
proteomics |
2 |
renal function |
2 |
sex disparity |
2 |
sex hormone binding globulin |
2 |
thrombin |
2 |
von willebrand factor |
2 |
white blood cell |
2 |
3-hydroxyisobutyrate |
1 |
adiposity |
1 |
antihypertensive drugs |
1 |
branch-chain amino acids |
1 |
breast cancer |
1 |
citation bias |
1 |
european population |
1 |
genetically predicted |
1 |
hormones |
1 |
interventions |
1 |
iron status |
1 |
lipid profiles |
1 |
mental disorders |
1 |
nitrogen oxides |
1 |
non-alcoholic fatty liver disease |
1 |
processed meat |
1 |
red meat |
1 |
sex-specific |
1 |
sibling controls |
1 |
survival bias |
1 |
systematic review |
1 |
two-sample mendelian randomization |
1 |